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tRNAs play a central role in protein translation, acting as the carrier of amino acids. By cloning
microRNAs, we unexpectedly obtained some tRNA fragments generated by tRNA cleavage in the
anticodon loop. These tRNA fragments are present in many cell lines and different mouse tissues.
In addition, various stress conditions can induce this tRNA cleavage event in mammalian cells. More
importantly, angiogenin (ANG), a member of RNase A superfamily, appears to be the nuclease which
cleaves tRNAs into tRNA halves in vitro and in vivo. These results imply that angiogenin plays an
important physiological role in cell stress response, except for the known function of inducing
angiogenesis.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction be polyadenylated by Trf4 complex, subsequently degraded bytRNAs play a key role in protein synthesis. They provide adaptors
for the process in which triplet codons are translated into amino
acids, and the vehicles which transport amino acids to ribosome
[1]. Past researches on tRNAsmainly focus on their structure, matu-
ration and the correlative function in protein synthesis, and little is
known about their degradation process. Actually, many factors may
lead to thedegradationof tRNAs, including themutationof itself, the
inactivation of tRNAs processing or modifying enzyme [2,3].
Many genes responsible for tRNA modiﬁcations in the antico-
don region play a major role in translation or growth [4]. By con-
trast, the numerous tRNA modiﬁcations outside of the anticodon
region have long been considered ancillary. However, Alexandrov
et al. [5], have reported that the mutation of any of the three en-
zymes which are among several non-necessary basi-modifying en-
zymes outside the anticodon loop of tRNAs results in Val-tRNAACC
lacking certain pairs of tRNA modiﬁcations, these tRNAs are
quickly degraded, and thus lead to temperature-sensitive growth.
This rapid tRNA degradation pathway acts on Val-tRNAAAC as fast
as for some mRNA species, which demonstrates a critical role of
non-essential modiﬁcations for tRNA stability and cell survival [5].
Base mutation can also affect the stability of tRNA molecules.
Keller et al. [6] have veriﬁed that DU13 mutant of Ala-tRNA canchemical Societies. Published by E
itative real-time polymeraseexosome, whereas none activity was observed with native Ala-
tRNA. These results and additional experiments with other tRNA
substrates suggest that the Trf4 complex can discriminate between
native tRNAs and molecules that are incorrectly folded. There are
kinds of mechanisms to ensure the ﬁdelity of macromolecular
duplication, transcription and translation in organismic gene
expression system, but mutants with mutated base still unavoid-
ably generate. The production of these RNA mutants with mutated
base represses translation and thereby severely effects cellular
normal metabolism [6]. The tRNA quality control mechanism of
tRNAs in cells can remove the tRNAs containing base mutation in
time, and so maintains cellular normal metabolism and growth.
All above are about the degradation mechanism of abnormal
tRNAs, but the degradation pathway of normal mature tRNAs re-
mains poorly elucidated. By cloning microRNAs from human fetus
hepatic tissue [7], we unexpectedly obtained some cleaved tRNA
sequences. In this work, we demonstrate that this tRNA cleavage
event in mammalian cells is induced by various stress conditions,
such as nutrition deﬁciency, hypoxia and hypothermia. More
importantly, we reveal that angiogenin (ANG), a ribonuclease in
the RNase A superfamily, appears to be the nuclease which cleaves
tRNAs into tRNA halves.2. Materials and methods
2.1. Cell culture and exposure condition
HepG2, HeLa and other cell lines were grown in DMEM contain-
ing 10% FBS and penicillin/streptomycin. For nutrition starvationlsevier B.V. All rights reserved.
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becco’s PBS for the indicated times [8]. For serum starvation stud-
ies, cells were washed and medium were replaced with serum-free
DMEM for the indicated times [9]. For c-irradiation exposure
group, cells were exposed to a ﬁnal dose of 8Gy or 10Gy (60Co)
[10]. For hypoxia treatment, cells were incubated with DMEM con-
taining 100 lM CoCl2 for 1 h or 12 h at 37 C [11]. For hypothermia
treatment, cells were incubated at 16 C for 40 min, and then incu-
bated at 37 C for 30 min. For heat shock treatment, cells were
incubated at 42 C for 40 min, and then incubated at 37 C for
30 min [12].
2.2. Tissue starvation
Fresh tissues of mouse liver and heart were kept in PBS buffers
for 30 min, 1 h, 3 h, 5 h, 7 h and 12 h at room temperature, respec-
tively, and then total RNAs were extracted.
2.3. RNA extraction and cloning
Total RNA was extracted from the cultured cells by using Trizol
(Invitrogen, Carlsbad, CA) according to the manufacturer’s proto-
col. Small RNA (6200 nt) was extracted from cells and human fetal
liver tissue using mirVanaTM miRNA Isolation kit (Ambion, Austin,
TX) according to the manufacturer’s instructions. The concentra-
tion of RNA was measured by the UV absorbance at 260 nm. RNA
cloning was performed according to the method described previ-
ous [7].
2.4. RNA sequence Computational analyses
RNA sequences were subjected to BLAST analyses against the
human genome (http://www.ncbi.nlm.nih.gov/blast).
2.5. Expression vector construction and transfection
The angiogenin coding sequence was ampliﬁed by polymerase
chain reaction (PCR) from HepG2 cDNA with primers 50-GTCAA-
GCTTCTGTGTTGGAAGAGATGGTGA-30 and 50-CCACTCGAGCCGC-
TGGTTACGGACGACGGA-30. Then the PCR product was cleaved
with EcoRI and XhoI and ligated into EcoRI/XhoI-cut pcDNA3.0.
The resulting plasmid was named pcDNA-ANG. DNA transfection
was performed with Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s protocol. Total RNAs and proteins were pre-
pared 48 h after transfection.
2.6. siRNAs and transfection
The siRNAs were synthesized by GeneChem (Shanghai, China).
The target sequences of angiogenin siRNA were: (1) ACGUUGUUG-
UUGCUUGUGA; (2) CCUAAGAAUAAGCAAGU CU; and (3) AGGCCA-
UCUGUGAAAACAA. The sequence of negative control was
UUAAGUAGCUUGGCCUUGA. siRNAs transfection in HepG2 cells
were performed with Lipofectamine 2000 (Invitrogen) according
to its protocol. In brief, cells were cultured in 6-well plate to 40%
conﬂuence. For each well, 5 ll siRNA (20 lM) was added into
250 ll Opti-MEM medium, 5 ll of Lipofectamine 2000 into
250 ll Opti-MEM medium, and then mixed siRNA with Lipofect-
amine 2000. The mixture was added to cells and incubated for
6 h before replacing the medium. Total RNAs and proteins were
prepared 48 h after transfection.
2.7. Northern blot
Northern blot was performed according to the method de-
scribed previously [7]. The probes used for Northern blot were 50end of Gly-tRNA: 50-GCAGGCGAGAATTCTACCACTGAACCACCAAT-
GC-30; 30 end of Gly-tRNA: 50-GCATTGGCCAGGAATCGAAGCCCGG-
30; 50 end of Val-tRNA: 50-GUUUCCGUAGUGUAGUGGUUAUCAC-
GUUCGCC-30;50 end of Met-tRNA: 50-AGCACGCTTCCGCTGCGC-
CACTCTGCT-30; 50 end of Arg-tRNA: 50-GGGCCAGTGGCGCAATGG-
ATAACGCGT-30; 50 end of Tyr-tRNA: 50-TCCGCTCTACCAGCTGAGC-
TATCGAAGG-30.
2.8. Quantitative real-time polymerase chain reaction (qRT-PCR)
qRT-PCR was used to conﬁrm the siRNA-mediated knock-down
of angiogenin mRNA. Reverse transcription was performed accord-
ing to the protocol of Impro-II Reverse Transcriptase (Promega),
qPCR was performed as described in the method of SYBR premix
Ex Taq (TaKaRa, Dalian, China) with IQ5 (Bio-Rad) supplied with
analytical software. GAPDH mRNA levels were used for normaliza-
tion. Sequences of oligonucleotide primers for qRT-PCR were:
angiogenin, 50-CACACTTCCTGACCCAGCACTA-30 and 50-TTCTCTGT-
GAGGGTTTCCATTC-30; GAPDH, 50-TCAGTGGTGGACCTGACCTG-30
and 50-TGCTGTAGCCAAATTCGTTG-30.
2.9. RNA cleavage reaction in vitro
For RNA cleavage reaction, incubation mixtures contained 20 lg
of total RNA extracted from HepG2 cells, 1 lM angiogenin (90%,
Cancer Institute, Chinese Academy of Medical Science, Beijing,
China), 30 mMHEPES, pH 6.8, 30 mMNaCl, 0.001%BSA. Incubations
were carried out at 37 C for 10 min, 30 min, 1 h or 2 h. Then the
cleaved products were recovered by phenol/chloroform extraction
followed by ethanol precipitation [13].
2.10. Western-blot analysis
Protein extracts were prepared by a modiﬁed RIPA buffer with
0.5% sodium dodecyl sulfate (SDS) in the presence of proteinase
inhibitor cocktail (Complete mini, Roche). Polyacrylamide gel elec-
trophoresis, tank-based transfer to Immobilon Hybond-C mem-
branes (Amersham Biosciences), and immunodetection were
performed with standard techniques. Antibodies against ANG (sc-
1408, Santa Cruz), and b-actin (sc-1616-R, Santa Cruz) were used
in Western-blot analysis in accordance with the manufacturer’s
instruction. Signals were visualized with SuperSignal West Pico
chemoluminescent substrate (Pierce) by exposure to ﬁlms.3. Results and discussion
3.1. Identiﬁcation of cleaved mammalian tRNA fragments
When we tried to clone microRNAs from human fetus hepatic
tissue, we unexpectedly have obtained a distinct population of
31–38nt cleaved tRNA fragments [7]. These tRNA fragments corre-
spond to ﬁve different kinds of tRNAs (Table 1). Intriguingly, they
do not appear to result from the random degradation of tRNAs,
but instead correspond to ‘halves’ of tRNAs located either 50 or 30
of the anticodon sequence. None of these tRNA fragments contains
50 leader or 30 trailer sequences of pre-tRNA, moreover, the precur-
sors of these tRNAs have no intervening sequences, which suggest
that these tRNA fragments are generated from fully mature tRNAs
rather than from nascent tRNA transcripts. In other words, the ob-
served tRNA halves were derived from cleavage within the antico-
don loop of mature tRNAs by speciﬁc endonuclease.
To determine whether these tRNA fragments were products of
speciﬁc cleavage or random degradation, we analyzed individual
tRNA by Northern blot. Small RNAs (6200nt) were extracted from
fetal liver, HepG2, BEL-7402, HeLa, A549, HEK-293 and Cos7 cell
Table 1
Summary of cleaved tRNA fragments.
Name Sequence No. of clonesa Size (nt) 50 or 30b
Gly-tRNAGCC GCATTGGTGGTTCAGTGGTAGAATTCTCGCCTGCC 19 32–35 5
Gly-tRNACCC GCGCCGCTGGTGTAGTGGTATCATGCAAGAT 4 31 5
Val-tRNAAAC GTTTCCGTAGTGTAGTGGTTATCACGTTCGCCT 11 32–33 5
Glu-tRNACTC TCCCTGGTGGTCTAGTGGTTAGGATTCGGCGCT 7 33–35 5
Arg-tRNACCG GGATCAGAAGATTGAGGGTTCGGGTCCCTTCGTGGTCG 2 38 3
Sequences listed represent the longest sequence of each kind of tRNA halves identiﬁed in this study.
a Number of clones.
b tRNA fragments are 50 or 30 ends of intact tRNA.
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complementary to the 50 end and 30 end of Gly-tRNAGCC, respec-
tively. As shown in Fig. 1, not only intact tRNAs, but also both 50
end and 30 end of Gly-tRNAGCC were detected in all tissue and cell
lines. The tRNA halves detected in fetal liver were much more than
those of other cell lines. This revealed that the tRNA fragments we
cloned were products of speciﬁc cleavage of intact tRNAs. Although
we have not cloned 30 end sequence of Gly-tRNAGCC, it was de-
tected by Northern blot suggesting that the kinds of tRNA halves
were more than those of we cloned.
3.2. Stress conditions induce the production of tRNA halves
Given that fetus hepatic tissue had been kept outside the body
for a few hours before RNA was extracted, we selected mouse liver
and heart tissues to analyze the cause of tRNA halves generation.
First, we extracted total RNAs from liver and heart as soon as the
mouse was killed, and the remaining parts of liver and heart were
kept in PBS buffer at room temperature. Then total RNAs were ex-
tracted from these tissues at different time point, such as 30 min,Fig. 1. Detection of the 50 and 30 halves of Gly-tRNA by Northern blot. (a) tRNA
halves were detected by the probe complementary to the 50 sequence of Gly-
tRNAGCC and (b) tRNA halves were detected by the probe complementary to the 30
sequence of Gly-tRNAGCC. Total RNAs were extracted from fetal liver tissue and
diverse cell lines, and analyzed by Northern blot.1 h, 3 h, 5 h, 7 h and 12 h, respectively. These total RNAs were ana-
lyzed with the probe complementary to the 50 end of Val-tRNA.
Northern blot analysis indicated that the levels of tRNA halves in
normal liver tissue and heart tissue were low, but they increased
when these tissues were kept in PBS, and the levels of tRNA halves
reached to maximum at 3 h (Fig. 2). These results suggest that the
generation of tRNA halves may be induced by nutrition deﬁciency.
To investigate whether this is the same case for cells cultured in
vitro, total RNAs were extracted from HepG2 cells cultured in PBS
or DMEM without serum. The tRNA halves derived from Gly-tRNA,
Val-tRNA, Met-tRNA, Arg-tRNA and Tyr-RNA were analyzed by
Northern blot. The result revealed that nutrition deﬁciency could
induce the production of multiple tRNA halves in cells cultured
in vitro indeed (Fig. 3). 50 half fragment of Met-tRNA has not been
cloned by our strategy, but it was detected by Northern blot
(Fig. 3c), which suggested that more kinds of tRNAs than those
we cloned could be cleaved into tRNA halves under certain condi-
tions. Lee et al. found that tRNA halves generated in tetrahymena
thermophila cells lacking essential amino acids, and that the addi-
tion of these essential amino acids could inhibit the production
of tRNA halves [14]. However, tRNA halves could generate in
human tumor cells either cultured in PBS or DMEM (rich of essential
amino acids) without serum (Fig. 3). That is to say, only essentialFig. 2. tRNA halves investigated by Northern blot in starvation tissues. (a) tRNA
halves were detected by the probe complementary to the 50 sequence of Val-
tRNAAAC in liver tissue and (b) tRNA halves were detected by the probe comple-
mentary to the 50 sequence of Val-tRNAAAC in heart tissue. Total RNAs were
extracted from mouse liver and heart tissue at different time point, and analyzed
with 50 speciﬁc probe of Val-tRNAAAC. As a loading control, 5.8S RNAs were stained
with ethidium bromide (EtBr).
Fig. 3. Analysis of different tRNA halves in starvation HepG2 Cells by Northern blot. (a) tRNA halves were detected by the probe complementary to the 50 sequence of Gly-
tRNAGCC; (b) tRNA halves were detected by the probe complementary to the 50 sequence of Val-tRNAAAC; (c) tRNA halves were detected by the probe complementary to the 50
sequence of Met-tRNACAT; (d) tRNA halves were detected by the probe complementary to the 50 sequence of Arg-tRNAACG; and (e) tRNA halves were detected by the probe
complementary to the 50 sequence of Tyr-tRNAGTA. (a) and (c) were from the same membrane, as were (b) and (d). Total RNAs extracted from HepG2 cells cultured in PBS or
DMEM without serum were analyzed by Northern blot with probes against diverse tRNAs. As a loading control, 5.8S RNAs were stained with ethidium bromide (EtBr).
Fig. 4. Stress conditions induce tRNA cleavage. The probe complementary to the 50
sequence of Val-tRNAAAC was used to detect the tRNA halves. Multiple stress
conditions, such as nutrition deﬁciency, heat shock, hypothermia and hypoxia, can
trigger tRNA cleavage and lead to the generation of tRNA halves in mammalian
cells. As a loading control, 5.8S RNAs were stained with ethidium bromide (EtBr).
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malian cells.
As shown in Fig. 3e, not all types of tRNAs were cleaved into
tRNA halves under the condition of nutrition deﬁciency. We could
detect intact Tyr-tRNAGTA but not its cleaved fragments from cells
treated with both PBS starvation and non-serum starvation
(Fig. 3e). That means the production of its tRNA halves could not
be induced by nutrition deﬁciency. However, the level of Tyr-
tRNAGTA decreased signiﬁcantly when cells were cultured in PBS
for 7 h. The length of Tyr-tRNAGTA is 90nt, but the lengths of other
tRNAs such as Gly-tRNA, Val-tRNA and Met-tRNA, are 70nt. That
suggests the structure of Tyr-tRNAGTA may be different from other
tRNAs, and it might be cleaved at other sites instead of anticodon
loop.
To further analyze the reasons of tRNA halves generation,
HepG2 cells were treated with several stress conditions such
as heat shock, hypothermia, hypoxia or irradiation. Northern blot
analysis showed the levels of cleaved Val-tRNA fragment in-
creased in cells treated with PBS starvation for 30 min, heat
shock at 42 C, hypothermia treatment at 16 C, hypoxia by CoCl2
for 1 h or hypoxia by CoCl2 for 12 h (Fig. 4). And hypothermia
treatment had the most signiﬁcant effects on the production of
tRNA halves. However, irradiation had no distinct effects on
the production of tRNA halves. These results reveal that not only
nutrition deﬁciency but also multiple stress conditions can trig-
ger tRNA cleavage and lead to the generation of tRNA halves in
mammalian cells.3.3. Angiogenin can cleave tRNAs in the anticodon loop in vitro
The tRNAs can be cleaved in the anticodon loop and processed
into tRNA halves under the conditions of nutrition deﬁciency or
stress. This cleavage may be catalyzed by a site-speciﬁc nuclease
that recognizes speciﬁc tRNA structure. Anticodon loop cleavage
of tRNAs has been observed in prokaryotes, the prokaryotic plas-
Fig. 5. tRNAs can be cleaved by angiogenin in the anticodon loop in vitro. Total
RNAs of HepG2 were isolated and cleaved by puriﬁed angiogenin in vitro for
different time. And the processed RNAs were used to probe Val-tRNAAAC halves by
Northern blot.
H. Fu et al. / FEBS Letters 583 (2009) 437–442 441mid-encoded Colicins and the anticodon nuclease PrrC target
tRNAs for cleavage in the anticodon loop in response to stress-in-
duced signals and T4 phage infection, respectively [15,16]. Unlike
the global tRNA cleavage that we have observed here, these mole-
cules can only act on several speciﬁc tRNAs. In addition, BLAST
searches suggest that there are no similar proteins in human cells
(data not shown). Thus, other RNases should be responsible for
cleavage of tRNAs induced by stress condition.
Saxena et al. have reported that angiogenin (ANG), a member of
RNase A superfamily, can degrade tRNAs and inhibit protein syn-
thesis when injected into Xenopus oocytes [17]. To verify whether
tRNAs can be cleaved into tRNA halves by angiogenin, 20 lg total
RNAs were incubated with 1lM recombinant angiogenin in vitro
at 37 C for 10 min, 30 min, 1 h and 2 h, respectively. Northern blot
results showed that most of the intact Val-tRNA was cleaved into
short tRNA halves after 10 min (Fig. 5). And the longer total RNAs
were incubated, the more intact tRNAs were cleaved. When total
RNAs were incubated with angiogenin for 2 h, almost all intactFig. 6. Identiﬁcation of tRNA halves in angiogenin over-expression HeLa cells by
Northern blot. (a) Western-blot analysis of angiogenin protein in HeLa cells
transfected with pcDNA3.0 or pcDNA-ANG. Antibody against b-actin was used as a
loading control. (b) Total RNAs were extracted from HeLa cells transfected with
pcDNA3.0 and pcDNA-ANG respectively, and the probes targeting 50 sequence of
different tRNA were used to detect the tRNA halves in HeLa cells. As a loading
control, 5.8S RNAs were stained with ethidium bromide (EtBr).tRNAs and cleaved tRNA halves were degraded. These results sug-
gest that the production of tRNA halves initiates a complete degra-
dation pathway for targeted tRNAs.
3.4. Angiogenin cleaves tRNAs into tRNA halves in vivo
To test whether angiogenin could cleave tRNAs in cultured
mammalian cells, HeLa cells were transiently transfected with
the plasmid expressing angiogenin. Cellular total RNAs were ex-
tracted 48 h after transfection and analyzed by Northern blot using
probes targeted to 50 ends of Met-tRNA, Tyr-tRNA and Val-tRNA,
respectively. As shown in Fig. 6, 50 ends tRNA halves of Met-tRNA
and Val-tRNA were detected in angiogenin over-expressing cells
but not in negative control samples. However, we detected no half
fragment of Tyr-tRNA in angiogenin over-expressing cells, which
coincided with our previous results that its tRNA halves were not
detected in starving cells. These results suggest that angiogenin
is probably the endonuclease for producing tRNA halves in vivo.
In order to analyze the role of endogenous angiogenin in
production of tRNA halves, HepG2 cells were transfected with
chemically synthesized siRNAs against angiogenin. And their
knock-down efﬁciency was analyzed by qRT-PCR. All three siRNAs
can reduce the mRNA levels of angiogenin, and siANG-1 has signif-
icant inhibition effect on the expression of angiogenin (Fig. 7a and
b), so it was used in the following experiment. HepG2 cells were
transfected with siANG-1 and control siRNA, respectively, 48 h
after transfection, the medium was replaced with PBS for 30 min.
Then the total RNAs were extracted and analyzed for the produc-Fig. 7. Decrease of angiogenin inhibiting the generation of tRNA halves in HepG2
cells. (a) Analysis of mRNA level by qRT-CR for angiogenin after treatment of HepG2
cells with siRNA against angiogenin, with negative siRNA (left) as negative control.
The error bars are derived from triplicate qRT-PCR using the same source of cDNA.
(b) The effectiveness of siRNA against ANG protein was analyzed by Western blot.
Antibody against b-actin was used as a loading control. (c) tRNA halves were
detected by Northern blot when angiogenin was inhibited by siRNA. The probe
complementary to 50 sequence of Val-tRNAAAC was used to detect Val-tRNA halves.
As a loading control, 5.8S RNAs were stained with ethidium bromide (EtBr).
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with normal DMEM medium had no signiﬁcant effects on the pro-
duction of tRNA halves (Fig. 7c). But comparing with negative siR-
NA control, siANG-1 inhibited the production of tRNA halves in
cells treated with PBS (nutrition deﬁciency), which suggests that
angiogenin is essential for the production of tRNAs halves in
starved mammalian cells. Angiogenin is a member of the RNase
superfamily, and plays an important role in eliciting new blood
vessel growth, angiogenesis [18]. By regulating angiogenesis,
angiogenin is closely related to tumor growth and progression,
and even its aggressiveness [19]. Site-directed mutagenesis studies
have shown the intact RNase active site is crucial for angiogenesis
[20]. However, its intracellular natural substrate is not clear. Here
we have found that tRNAs can be cleaved into tRNA halves by
angiogenin in vitro and in vivo (Figs. 5 and 6), suggesting tRNAs
may be natural substrates of angiogenin in mammalian cells. These
tRNA halves have accumulated under various stress conditions
(Fig. 4), however, no signiﬁcant angiogenin protein levels alter-
ation was detected (Fig. S1). That might because tRNA cleavage
by angiogenin occurs preferentially for deacylated tRNAs lacking
30CCA. A fraction of deacylated tRNA may lose 30terminal CCA
nucleotides under stress conditions, and these truncated tRNAs
accumulate transiently [14]. Therefore, tRNA halves cleaved by
angiogenin accumulate without angiogenin protein levels
alteration.
Although tRNA halves have been identiﬁed in various species
such as Streptomyces coelicolor [21], Tetrahymena thermophila
[14], Caenorhabditis elegans [22] and mammalian cells, the biolog-
ical function of tRNA cleavage is still unclear. It is conceivable that
the tRNA cleavage could serve as a mechanism to eliminate redun-
dant tRNA molecules, especially those uncharged and/or 30-trun-
cated tRNAs. Targeting redundant tRNAs for degradation may
save more essential nutritive material to maintain longer term sur-
vival under nutrient-poor conditions. Another possibility is that
cleaved tRNA halves might act as signaling molecules to regulate
genes. For example, mRNAs of inﬂuenza virus and HIV-1 can be
cleaved by the RNases (RNase P and RNase Z) with external guide
sequence (EGS), which is an RNA similar to tRNA halves form and
plays its role as a guide to specify its target RNAs [23,24]. These
RNases may use the cleaved product of tRNA identiﬁed here as a
guide to regulate the expression of target genes. The ribonucleoly-
tic activity of angiogenin is crucial for its angiogenic activity [20],
here we demonstrate that tRNAs are natural substrates of angioge-
nin in mammalian cells. Then it is also possible that tRNA cleavage
by angiogenin plays a role in the angiogenesis process. All of the
above hypotheses, based on our novel data, await future experi-
mental validation.
In summary, our data show that tRNA halves are commonly
found in diverse mammalian cells, and this tRNA cleavage event
can be induced by multiple stress conditions. In addition, angioge-
nin, a member of RNase A superfamily, appears to be the nuclease
which cleaves tRNAs into tRNA halves in vitro and in vivo. That is
to say, tRNAs are natural substrates of the ribonucleolytic activity
of angiogenin, although the biological function of these tRNA
halves remains to be elucidated.Acknowledgements
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